Earnings Alerts

Formosa Chemicals & Fibre (1326) Earnings: August Sales Climb to NT$29.37B with 1.01% Increase

By September 6, 2024 No Comments
  • Formosa Chemicals’ August Sales: NT$29.37 billion
  • Sales Growth: +1.01%
  • Stock Recommendations:
    • 1 Buy
    • 11 Holds
    • 3 Sells

A look at Formosa Chemicals & Fibre Smart Scores

FactorScoreMagnitude
Value5
Dividend4
Growth2
Resilience3
Momentum2
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Formosa Chemicals & Fibre Corporation holds a promising long-term outlook based on the Smartkarma Smart Scores analysis. With a top-notch Value score of 5, the company is deemed to be attractively priced relative to its intrinsic value. Coupled with a solid Dividend score of 4, indicating a healthy dividend payout, Formosa Chemicals & Fibre presents an appealing proposition to investors seeking stable returns.

While the Growth and Momentum scores stand at 2, suggesting moderate growth potential and momentum in the near term, the company showcases Resilience with a score of 3, indicating a certain level of stability and durability. Overall, Formosa Chemicals & Fibre‘s strong Value and Dividend scores position it favorably for long-term growth and income generation, making it a noteworthy player in the petrochemical products and fiber market.

Summary: Formosa Chemicals & Fibre Corporation excels in manufacturing and marketing petrochemical products, nylon fiber, and rayon staple fiber. Its strong presence in Taiwan and the Asian export market coupled with impressive Value and Dividend scores make it a compelling choice for investors looking for a balanced investment opportunity.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars